Uttam Dhillon is now the Trump administration's third-consecutive acting administrator for the DEA -- which oversees the federal response to the opioid epidemic. Some law enforcement groups have voiced opposition to Dhillon's appointment. Meanwhile, the FDA is likely to approve a powerful opioid despite the disapproval from the head of the agency's advisory panel.

from Kaiser Health News https://ift.tt/2D9PWk2

Related Posts:

0 comments:

Post a Comment

Popular Posts